Table 4.

Time alive and time free of diabetes-related complications

Diabetes-related complications	Increased risk for hypoglycemia cohort (years)			Uncontrolled HbA1c at baseline cohort
	SAP with automated insulin suspension arm	CSII-alone arm	Δ	SAP with automated insulin suspension arm	CSII-alone arm	Δ
Proliferative retinopathy	30.80	30.46	0.34	19.17	18.28	0.89
Microalbuminuria	15.22	15.12	0.10	10.66	9.87	0.79
Gross proteinuria	33.04	32.67	0.37	19.29	18.37	0.92
End-stage renal disease	36.42	35.98	0.44	21.70	20.90	0.80
First ulcer	29.43	29.11	0.32	19.10	18.18	0.92
Amputation	34.67	34.27	0.40	21.42	20.63	0.79
Neuropathy	19.87	19.70	0.17	14.16	13.12	1.04
Peripheral vascular disease	35.50	35.10	0.40	20.94	20.20	0.74
Congestive heart failure	35.55	35.13	0.42	21.12	20.36	0.76
Angina	35.22	34.83	0.39	19.85	19.15	0.70
Myocardial infarction	35.74	35.31	0.43	20.39	19.69	0.70
Stroke	34.86	34.46	0.40	19.22	18.58	0.64
Cataract	31.55	31.18	0.37	19.86	19.22	0.64
Macula edema	22.72	22.54	0.18	15.21	14.56	0.65
Severe vision loss	27.22	26.98	0.24	18.20	17.55	0.65

Time alive and time free of complications are shown in years